Pharma company Alkem Laboratories has informed after the close of the stock market on Friday that its subsidiary Alkem Medtech Private Limited is going to buy a major stake in Switzerland’s medical device company Occlutech Holding AG. The company said in the information given to the stock market that its subsidiary will acquire a minimum 51 percent and maximum 55 percent stake in Occlutech. The company said that in this regard, a Share Purchase Agreement (SPA) has been signed with the existing shareholders of Occlutech on March 6, 2026.
Alkem Laboratories Share: Announcement to buy 51-55 percent stake in Switzerland’s medical device company – Market
